Limb; Fusion

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Limb; Fusion trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT06160752

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of TYRA-200 in cancers with FGFR2 a…

United States40 participantsStarted 2023-11-22

Treatment: Phase 1 Part A - dose escalation TYRA-200 taken once daily by mouth in 28-day cycles, Phase 1 Part B - dose expansion TYRA-200 taken once daily by mouth in 28-day cycles

All recent trials (12 shown)

Active — Not RecruitingPhase 1

NCT05567185

A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer

The purpose of the study is to determine the tolerability of erdafitinib intravesical delivery system (TAR-210) in Japanese participants.

Japan5 participantsStarted 2023-03-03

Treatment: Erdafitinib Intravesical Delivery System

CompletedNot Applicable

NCT06272760

Development of a Remote Therapy Protocol for Upper Limb Function Enhancement in Children With Cerebral Palsy

The perpose of this study: Development and demonstration of a teletherapy protocol to improve upper limb function in children with cerebral palsy.

South Korea29 participantsStarted 2024-12-01

Treatment: Home-based hand-arm bimanual intensive training (Tele-HABIT)

Limb; Fusion

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

All recent trials (12 shown)

A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer

Development of a Remote Therapy Protocol for Upper Limb Function Enhancement in Children With Cerebral Palsy

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

All recent trials (12 shown)

A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer

Development of a Remote Therapy Protocol for Upper Limb Function Enhancement in Children With Cerebral Palsy

A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Fact…

Short-term Outcomes of High Tibial Osteotomy Using a Plate Versus a Plate With an Interbody Fusion Cage in Adolescent Ti…

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small…

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Ext…

Application of Antiosteoporosis Therapy in Osteolysis

Investigating Auto Adjusting Dynamic AFO

Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupiva…

Phase 1 Dose-finding Study of L19TNFα Plus Melphalan Using Isolated Inferior Limb Perfusion (ILP) in Subjects With Intra…

Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmaco…